Name | Description | Size | Catalog # | Supplier | |
---|---|---|---|---|---|
10074-A4 | An inhibitor of the protein-protein interaction between c-Myc and Max; inh… | 25 mg | 37486-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
10074-A4 | An inhibitor of the protein-protein interaction between c-Myc and Max; inh… | 5 mg | 37486-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
852A | A TLR7 agonist; selectively induces NF-κB signaling in HEK293 cells… | 1 mg | 39512-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
852A | A TLR7 agonist; selectively induces NF-κB signaling in HEK293 cells… | 10 mg | 39512-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
852A | A TLR7 agonist; selectively induces NF-κB signaling in HEK293 cells… | 25 mg | 39512-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
852A | A TLR7 agonist; selectively induces NF-κB signaling in HEK293 cells… | 5 mg | 39512-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A 83-01 | An inhibitor of ALK5, ALK4, and ALK7 (IC50s = 12, 45, and 7.5 nM, respecti… | 1 mg | 9001799-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A 83-01 | An inhibitor of ALK5, ALK4, and ALK7 (IC50s = 12, 45, and 7.5 nM, respecti… | 10 mg | 9001799-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A 83-01 | An inhibitor of ALK5, ALK4, and ALK7 (IC50s = 12, 45, and 7.5 nM, respecti… | 25 mg | 9001799-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A 83-01 | An inhibitor of ALK5, ALK4, and ALK7 (IC50s = 12, 45, and 7.5 nM, respecti… | 5 mg | 9001799-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A01 | A Smurf1 inhibitor (Kd = 3.67 nM); inhibits Smurf1-mediated ubiquitination… | 10 mg | 26137-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A01 | A Smurf1 inhibitor (Kd = 3.67 nM); inhibits Smurf1-mediated ubiquitination… | 25 mg | 26137-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A01 | A Smurf1 inhibitor (Kd = 3.67 nM); inhibits Smurf1-mediated ubiquitination… | 5 mg | 26137-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A01 | A Smurf1 inhibitor (Kd = 3.67 nM); inhibits Smurf1-mediated ubiquitination… | 50 mg | 26137-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
A011 | An inhibitor of ATM kinase (IC50 = 1 nM); selective for ATM over a panel o… | 1 mg | 39183-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A011 | An inhibitor of ATM kinase (IC50 = 1 nM); selective for ATM over a panel o… | 5 mg | 39183-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1070722 | A GSK3β inhibitor (IC50 = <100 nM) | 1 mg | 29783-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1070722 | A GSK3β inhibitor (IC50 = <100 nM) | 10 mg | 29783-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1070722 | A GSK3β inhibitor (IC50 = <100 nM) | 25 mg | 29783-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1070722 | A GSK3β inhibitor (IC50 = <100 nM) | 5 mg | 29783-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1120 | An RBP4 antagonist (Ki = 8.3 nM for disruption of RBP4 binding to transthy… | 10 mg | 30921-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1120 | An RBP4 antagonist (Ki = 8.3 nM for disruption of RBP4 binding to transthy… | 5 mg | 30921-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1155463 | A Bcl-xL inhibitor (Ki = is = 80 and 16 nM, respectively); inhibits the gr… | 1 mg | 27369-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1155463 | A Bcl-xL inhibitor (Ki = is = 80 and 16 nM, respectively); inhibits the gr… | 10 mg | 27369-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1155463 | A Bcl-xL inhibitor (Ki = is = 80 and 16 nM, respectively); inhibits the gr… | 25 mg | 27369-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1155463 | A Bcl-xL inhibitor (Ki = is = 80 and 16 nM, respectively); inhibits the gr… | 5 mg | 27369-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1210477 | A selective Mcl-1 inhibitor (Ki = 0.43 nM; IC50 = 26.2 nM); disrupts the i… | 1 mg | 21113-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1210477 | A selective Mcl-1 inhibitor (Ki = 0.43 nM; IC50 = 26.2 nM); disrupts the i… | 10 mg | 21113-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1210477 | A selective Mcl-1 inhibitor (Ki = 0.43 nM; IC50 = 26.2 nM); disrupts the i… | 25 mg | 21113-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1210477 | A selective Mcl-1 inhibitor (Ki = 0.43 nM; IC50 = 26.2 nM); disrupts the i… | 5 mg | 21113-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1331852 | An orally bioavailable Bcl-xL inhibitor; selectively binds Bcl-xL over Bcl… | 1 mg | 22963-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1331852 | An orally bioavailable Bcl-xL inhibitor; selectively binds Bcl-xL over Bcl… | 10 mg | 22963-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1331852 | An orally bioavailable Bcl-xL inhibitor; selectively binds Bcl-xL over Bcl… | 5 mg | 22963-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-196 | A selective inhibitor of SUV420H1 and SUV420H2 (IC50s = 25 and 144 nM, res… | 1 mg | 18317-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-196 | A selective inhibitor of SUV420H1 and SUV420H2 (IC50s = 25 and 144 nM, res… | 5 mg | 18317-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-196 | A selective inhibitor of SUV420H1 and SUV420H2 (IC50s = 25 and 144 nM, res… | 500 µg | 18317-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-205804 | A potent inhibitor of E-selectin and ICAM-1 expression in HUVECs stimulate… | 1 mg | 21252-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-205804 | A potent inhibitor of E-selectin and ICAM-1 expression in HUVECs stimulate… | 10 mg | 21252-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-205804 | A potent inhibitor of E-selectin and ICAM-1 expression in HUVECs stimulate… | 5 mg | 21252-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-205804 | A potent inhibitor of E-selectin and ICAM-1 expression in HUVECs stimulate… | 50 mg | 21252-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
A23187 | A calcium ionophore and a microbial metabolite; induces calcium overload a… | 1 mg | 11016-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A23187 | A calcium ionophore and a microbial metabolite; induces calcium overload a… | 10 mg | 11016-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A23187 | A calcium ionophore and a microbial metabolite; induces calcium overload a… | 25 mg | 11016-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A23187 | A calcium ionophore and a microbial metabolite; induces calcium overload a… | 5 mg | 11016-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A286982 | An inhibitor that blocks the integrin-ligand interaction between LFA-1 and… | 10 mg | 27646-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A286982 | An inhibitor that blocks the integrin-ligand interaction between LFA-1 and… | 25 mg | 27646-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A286982 | An inhibitor that blocks the integrin-ligand interaction between LFA-1 and… | 5 mg | 27646-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A286982 | An inhibitor that blocks the integrin-ligand interaction between LFA-1 and… | 50 mg | 27646-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-317491 | A P2X3 and P2X2 / 3 receptor antagonist (Kis = 22-92 nM in a calcium influ… | 1 mg | 19256-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-317491 | A P2X3 and P2X2 / 3 receptor antagonist (Kis = 22-92 nM in a calcium influ… | 10 mg | 19256-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-317491 | A P2X3 and P2X2 / 3 receptor antagonist (Kis = 22-92 nM in a calcium influ… | 25 mg | 19256-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-317491 | A P2X3 and P2X2 / 3 receptor antagonist (Kis = 22-92 nM in a calcium influ… | 5 mg | 19256-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-366 | A potent, peptide-competitive inhibitor of the lysine methyltransferase G9… | 10 mg | 16081-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-366 | A potent, peptide-competitive inhibitor of the lysine methyltransferase G9… | 5 mg | 16081-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-366 | A potent, peptide-competitive inhibitor of the lysine methyltransferase G9… | 50 mg | 16081-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-419259 | An inhibitor of Src family kinases, including Src, LCK, Lyn, and Hck (IC50… | 1 mg | 25605-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-419259 | An inhibitor of Src family kinases, including Src, LCK, Lyn, and Hck (IC50… | 10 mg | 25605-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-419259 | An inhibitor of Src family kinases, including Src, LCK, Lyn, and Hck (IC50… | 5 mg | 25605-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-443654 | A pan Akt inhibitor (Ki = 160 pmol / L for all three isoforms) that interf… | 1 mg | 16499-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-443654 | A pan Akt inhibitor (Ki = 160 pmol / L for all three isoforms) that interf… | 5 mg | 16499-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-443654 | A pan Akt inhibitor (Ki = 160 pmol / L for all three isoforms) that interf… | 500 µg | 16499-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-484954 | An eEF-2K inhibitor; reduces eEF-2K autophosphorylation in various cancer… | 1 mg | 28279-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-484954 | An eEF-2K inhibitor; reduces eEF-2K autophosphorylation in various cancer… | 10 mg | 28279-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-484954 | An eEF-2K inhibitor; reduces eEF-2K autophosphorylation in various cancer… | 25 mg | 28279-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-484954 | An eEF-2K inhibitor; reduces eEF-2K autophosphorylation in various cancer… | 5 mg | 28279-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-485 | A p300 / CBP inhibitor (IC50 = 60 nM); decreases H3K27Ac levels in PC3 cel… | 1 mg | 24119-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-485 | A p300 / CBP inhibitor (IC50 = 60 nM); decreases H3K27Ac levels in PC3 cel… | 10 mg | 24119-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-485 | A p300 / CBP inhibitor (IC50 = 60 nM); decreases H3K27Ac levels in PC3 cel… | 25 mg | 24119-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-485 | A p300 / CBP inhibitor (IC50 = 60 nM); decreases H3K27Ac levels in PC3 cel… | 5 mg | 24119-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-61603 | A selective α1A-adrenergic receptor agonist that is at least 35-fold… | 1 mg | 17358-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-61603 | A selective α1A-adrenergic receptor agonist that is at least 35-fold… | 10 mg | 17358-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-61603 | A selective α1A-adrenergic receptor agonist that is at least 35-fold… | 5 mg | 17358-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-66 | A potent, selective inhibitor of the PI3K isoform p110α (IC50 = 32 n… | 1 mg | 17382-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-66 | A potent, selective inhibitor of the PI3K isoform p110α (IC50 = 32 n… | 10 mg | 17382-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-66 | A potent, selective inhibitor of the PI3K isoform p110α (IC50 = 32 n… | 25 mg | 17382-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-66 | A potent, selective inhibitor of the PI3K isoform p110α (IC50 = 32 n… | 5 mg | 17382-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-674563 | An orally available, reversible inhibitor of Akt (Ki = 11 nM for Akt1); al… | 1 mg | 18715-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-674563 | An orally available, reversible inhibitor of Akt (Ki = 11 nM for Akt1); al… | 10 mg | 18715-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-674563 | An orally available, reversible inhibitor of Akt (Ki = 11 nM for Akt1); al… | 5 mg | 18715-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-674563 | An orally available, reversible inhibitor of Akt (Ki = 11 nM for Akt1); al… | 500 µg | 18715-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
A6770 | An inhibitor of S1P lyase; induces accumulation of [3H]dhS1P in IT-79MTNC3… | 1 mg | 29972-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A6770 | An inhibitor of S1P lyase; induces accumulation of [3H]dhS1P in IT-79MTNC3… | 10 mg | 29972-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A6770 | An inhibitor of S1P lyase; induces accumulation of [3H]dhS1P in IT-79MTNC3… | 5 mg | 29972-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A6770 | An inhibitor of S1P lyase; induces accumulation of [3H]dhS1P in IT-79MTNC3… | 500 µg | 29972-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-740003 | A selective P2X7 antagonist (IC50s = 40 and 18 nM for human and rat recept… | 1 mg | 21256-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-740003 | A selective P2X7 antagonist (IC50s = 40 and 18 nM for human and rat recept… | 10 mg | 21256-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-740003 | A selective P2X7 antagonist (IC50s = 40 and 18 nM for human and rat recept… | 25 mg | 21256-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-740003 | A selective P2X7 antagonist (IC50s = 40 and 18 nM for human and rat recept… | 5 mg | 21256-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-769662 | A direct activator of AMPK (EC50 = 116 nM in a cell-free assay); allosteri… | 10 mg | 11900-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-769662 | A direct activator of AMPK (EC50 = 116 nM in a cell-free assay); allosteri… | 25 mg | 11900-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-769662 | A direct activator of AMPK (EC50 = 116 nM in a cell-free assay); allosteri… | 5 mg | 11900-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-769662 | A direct activator of AMPK (EC50 = 116 nM in a cell-free assay); allosteri… | 50 mg | 11900-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-770041 | An orally bioavailable LCK kinase inhibitor (IC50 = 0.147 µM); selec… | 1 mg | 32854-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-770041 | An orally bioavailable LCK kinase inhibitor (IC50 = 0.147 µM); selec… | 5 mg | 32854-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-77-01 | A potent inhibitor of the TGF-β1 receptor ALK5 (IC550 = 25 nM), block… | 1 mg | 18396-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-77-01 | A potent inhibitor of the TGF-β1 receptor ALK5 (IC550 = 25 nM), block… | 10 mg | 18396-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-77-01 | A potent inhibitor of the TGF-β1 receptor ALK5 (IC550 = 25 nM), block… | 25 mg | 18396-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-77-01 | A potent inhibitor of the TGF-β1 receptor ALK5 (IC550 = 25 nM), block… | 5 mg | 18396-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-771726 | An active metabolite of leflunomide; inhibits DHODH (IC50 = 0.23 µM)… | 10 mg | 14404-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-771726 | An active metabolite of leflunomide; inhibits DHODH (IC50 = 0.23 µM)… | 25 mg | 14404-25 |
CAYMAN CHEMICAL COMPANY |
More Info |